Hif1α is required for osteoclast activation and bone loss in male osteoporosis
Toshimi Tando, Takeshi Miyamoto(Kumamoto Health Science University), Ryuichi Watanabe(Keio University), Mayu Morita(Keio University), Masaya Nakamura(Keio University), Atsushi Funayama(Keio University), Hao Wu(Capital Medical University), Tami Kobayashi(Keio University), Takatsugu Oike(Keio University), Morio Matsumoto(Keio University Hospital), Yoshiaki Toyama(Keio University), Arihiko Kanaji(Fujita Health University), Yuiko Sato(Keio University), Kana Miyamoto(Kumamoto University)
Cited by 32
Related Papers
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694
v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation
|Nature Medicine|2006|542
Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures
|Biochemical and Biophysical Research Communications|1998|344